Infected peripheral blood mononuclear cells (PBMC) effectively transport equine herpesvirus type 1 (EHV-1), but not EHV-4, to endothelial cells (EC) lining the blood vessels of the pregnant uterus or central nervous system, a process that can result in abortion or myeloencephalopathy. We examined, using a dynamic in vitro model, the differences between EHV-1 and EHV-4 infection of PBMC and PBMC-EC interactions. In order to evaluate viral transfer between infected PBMC and EC, cocultivation assays were performed. Only EHV-1 was transferred from PBMC to EC, and viral glycoprotein B (gB) was shown to be mainly responsible for this form of cell-to-cell transfer. For addressing the more dynamic aspects of PBMC-EC interaction, infected PBMC were perfused through a flow channel containing EC in the presence of neutralizing antibodies. By simulating capillary blood flow and analyzing the behavior of infected PBMC through live fluorescence imaging and automated cell tracking, we observed that EHV-1 was able to maintain tethering and rolling of infected PBMC on EC more effectively than EHV-4. Deletion of US3 reduced the ability of infected PBMC to tether and roll compared to that of cells infected with parental virus, which resulted in a significant reduction in virus transfer from PBMC to EC. Taking the results together, we conclude that systemic spread and EC infection by EHV-1, but not EHV-4, is caused by its ability to infect and/or reprogram mononuclear cells with respect to their tethering and rolling behavior on EC and consequent virus transfer.
IMPORTANCE
EHV-1 is widespread throughout the world and causes substantial economic losses through outbreaks of respiratory disease, abortion, and myeloencephalopathy. Despite many years of research, no fully protective vaccines have been developed, and several aspects of viral pathogenesis still need to be uncovered. In the current study, we investigated the molecular mechanisms that facilitate the cell-associated viremia, which is arguably the most important aspect of EHV-1 pathogenesis. The newly discovered functions of gB and pUS3 add new facets to their previously reported roles. Due to the conserved nature of cell-associated viremia among numerous herpesviruses, these results are also very relevant for viruses such as varicella-zoster virus, pseudorabies virus, human cytomegalovirus, and others. In addition, the constructed mutant and recombinant viruses exhibit potent in vitro replication but have significant defects in certain stages of the disease course. These viruses therefore show much promise as candidates for future live vaccines. E quine herpesvirus type 1 (EHV-1) and EHV-4 are members of the Herpesviridae family and Alphaherpesvirinae subfamily (1, 2) . After initial replication in the upper respiratory tract, EHV-1 infects immune cells and migrates past the epithelial basement membrane to the lymph nodes and bloodstream (1) (2) (3) (4) . As a result, EHV-1 is able to spread throughout the body, where it infects endothelial cells (EC), causing vascular lesions and secondary hypoxic degeneration of the affected tissues (3, 5, 6) . EHV-1 replication occurs mainly in the endothelial lining of blood vessels of the pregnant uterus and the central nervous system (CNS), which can ultimately lead to abortion or equine herpesvirus myeloencephalopathy (EHM), respectively (5) . EHV-4 on occasion also has a viremic phase, which is, however, of much lower magnitude and shorter duration, and its role in abortion and EHM is not as clear as for EHV-1 (5, 7) .
Infection of the peripheral blood mononuclear cells (PBMC) is a key aspect of viral spread and pathogenesis (8) . Besides EHV-1, other alphaherpesviruses, such as varicella zoster virus (VZV) and pseudorabies virus (PRV), have been shown to cause cell-associated viremia, which contributes to the widespread distribution of virus and infection of organs (9, 10) . EHV-1 can replicate in PBMC in a restricted fashion and apparently fails to establish a productive infection (11) (12) (13) . Earlier in vivo studies done in ponies identified T lymphocytes to be the most susceptible of the PBMC subpopulations (12, 14) . In contrast, in vitro studies indicated monocytes to be the primary target of EHV-1 (11) , which is in accordance with the case for PRV, where monocytes are important for virus transport throughout the body (15, 16) . Monocytes are also important for disseminating other herpesviruses, such as members of the Betaherpesvirinae. Human cytomegalovirus (HCMV) and murine cytomegalovirus (MCMV) rely on monocytes, in which these viruses also do not establish a productive infection, to spread the virus throughout the host (17) .
Another important aspect of EHV-1 pathogenesis is the viral transfer from infected PBMC to EC in the capillaries of the CNS and the gravid uterus (8) . It was hypothesized that EC infection is initiated upon close contact following adhesion of PBMC to EC and direct cell-to-cell transfer of virus, a mechanism that would not require viral egress from PBMC (8) . A recent study reported on virus transfer from PBMC to EC, where EHV-1-infected PBMC were cocultured on top of an EC monolayer in the presence of neutralizing antibodies. This demonstrated the potential importance of this mode of transfer during EHV-1 infection (18) . There are certain viral proteins that likely play key roles during the transfer from PBMC to EC. The viral glycoprotein B (gB) is one of these candidates, as it is known to be essential for direct cell-to-cell spread of EHV-1 and EHV-4 by facilitating membrane fusion between neighboring cells (19) (20) (21) . We posit that it is very likely that gB may take on a similar role in biologically relevant cells by mediating virus transfer from PBMC to EC.
Unfortunately, the stationary experimental setup does not allow the evaluation of initial PBMC-EC interactions, including PBMC tethering and rolling. A dynamic-flow setup could serve as a useful tool to analyze these initial PBMC-EC interactions. Tethering and rolling are known to be controlled mainly by adhesion molecules expressed on the surface of cells (22) (23) (24) . Up-or downregulation of these molecules on the surface of infected PBMC or EC may explain the preference of EHV-1 for such cells (8) . However, little is known about their up-or downregulation on the surface of EHV-1-or EHV-4-infected PBMC (25) . It would be interesting to evaluate whether these differences in adhesion molecule expression translate into changes in the ability of infected PBMC to tether and roll on EC under flow conditions.
The protein kinase encoded in the unique-short region (pUS3) could also very well be implicated in causing differences in adhesion molecule expression. pUS3 is a multifunctional protein that has been implicated in regulating a number of processes in infected cells, including modulating the actin skeleton to which adhesion molecules are anchored. For certain adhesion molecules it has been shown that the absence of actin filaments causes them to cluster, which in turn leads to increased adhesion (26) (27) (28) (29) (30) . Actin filament breakdown, a function conserved for numerous herpesvirus pUS3 orthologues (27, 31, 32) , could therefore indirectly induce increased adhesion activity of the infected PBMC. In addition, the antiapoptotic effects of pUS3 could also permit infected PBMC to continue functioning normally, allowing the PBMC to reach the target tissues with subsequent virus spread to uninfected endothelial cells.
In order to assess the behavior of infected PBMC tethering and rolling over EC, we developed an in vitro flow system that allowed us to monitor rolling PBMC through live imaging. To the best of our knowledge, this is the first report describing the kinetics of infected PBMC and showing virus transfer from infected PBMC to EC under flow condition. EHV-1, EHV-4, and EHV-1 deficient in US3 (EHV-1⌬US3) were evaluated in this system in order to uncover the different factors involved in viral spread between infected PBMC and EC.
MATERIALS AND METHODS
Viruses. All viruses used in the study were recovered from infectious bacterial artificial chromosome (BAC) clones. Those were BACs of EHV-1 strain Ab4 (33) and EHV-4 strain TH20p (34) , as well as modified BACs EHV-1_gB4, EHV-4_gB1, revertant EHV-1_gB1r (20) , EHV1_gD4, EHV-4_gD1 (35), EHV-1⌬US3, and EHV-1 that contained US3 of EHV-4 (EHV-1_US3_4) in lieu of authentic US3, fully rescuing the parental EHV-1 phenotype and functioning as revertant for this study (A. Proft and W. Azab, unpublished data). monomeric red fluorescent protein (mRFP1)-labeled EHV-1 was previously constructed by inserting mRFP1 into VP26 of EHV-1 strain RacL11 (36) . Viruses were grown on equine dermal (ED) cells. All viruses express enhanced green fluorescent protein (EGFP) for ready identification of infected cells.
Cells. Primary equine carotid artery endothelial cells (a kind gift from Ilka Slosarek, Freie Universität Berlin, Institut für Veterinär-Anatomie) were propagated in Dulbecco's modified Eagle's medium (DMEM) (Biochrom) supplemented with 20% fetal bovine serum (FBS) (Biochrom), 1% nonessential amino acids (Biochrom), and 1% penicillin-streptomycin. ED cells were grown in Iscove's modified Dulbecco's medium (IMDM) (Invitrogen) supplemented with 20% FBS, 1% nonessential amino acids (Biochrom) and 1% 100 mM sodium pyruvate (Biochrom).
Equine PBMC were isolated from heparinized blood collected from healthy horses by density gradient centrifugation over Histopaque 1077 (Sigma), following the manufacturer's instructions. After two washing steps, cells were suspended in RPMI 1640 (Biochrom) supplemented with 10% FBS, 0.3 mg/ml glutamine, nonessential amino acids, and 1% penicillin-streptomycin. Blood collection was done according to the rules of Institutional Animal Care and Use Committee of Berlin (Landesamt für Gesundheit und Sociales, L 0294/13).
Virus growth assay. To evaluate virus replication in PBMC in vitro, single-step growth kinetics were determined as described before (37) . Briefly, PBMC were infected with a multiplicity of infection (MOI) of 1. After 1 h of incubation, cells were washed and treated with citrate buffer (40 mM citric acid, 10 mM KCl, 135 mM NaCl, pH 3). Infected cells and supernatant were collected at the indicated time points postinfection (p.i.) and stored at Ϫ80°C. Viral titers were determined by titration on ED cells (38) .
Infection assay. For evaluating the rate of infection of PBMC over time, 1 ϫ 10 5 PBMC were infected at an MOI of either 0.1 or 1 with EHV-1 and EHV-4 at 37°C for 1 h. Afterwards, PBMC were incubated in citrate buffer and washed twice. After 24 h of incubation at 37°C, infection of PBMC with EHV-1 and EHV-4 was evaluated at different time points p.i. by means of flow cytometry. A FACSCalibur flow cytometer (BD Biosciences) and FlowJo software (TreeStar) were used to detect and analyze GFP expression in the infected PBMC. Dead cells were excluded by staining of the infected PBMC with propidium iodide (PI) at a final concentration of 10 g/ml.
For evaluating the rates of infection of the different PBMC subpopulations, 1 ϫ 10 5 infected PBMC were stained at 24 h p.i. with primary mouse antibodies against equine CD14 (monocytic lineage), CD3 (T lymphocytic lineage), or IgM (B lymphocytic lineage) (33) . Antibodies were kindly provided by Bettina Wagner, Cornell University, Ithaca, NY, USA. After washing, cells were labeled with a secondary Alexa Fluor 647-conjugated goat anti-mouse IgG antibody (Invitrogen) and analyzed by flow cytometry.
Aggregation assay. Twenty thousand PBMC were infected with either EHV-1 or EHV-4 at an MOI of 1 at 37°C for 1 h in a flat-bottom 96-well plate. The number and size of cell aggregates formed by each virus were evaluated at different time points after infection using an inverted fluorescence microscope (Zeiss Axiovert 100) and photographed with an AxioCam charge-coupled-device (CCD) camera (Zeiss). The size of the aggregates was measured using ImageJ software vl.32j (National Institutes of Health, Bethesda, MD, USA) (http://rsb.info.nih.gov/ij/).
Cocultivation assay. EC were grown to confluence in 24-well plates (Sarstedt). PBMC were infected with either parental or recombinant viruses at an MOI of 0.1 for 1 h. Successful infection was evaluated 24 h after infection by measuring the rates of infection of the PBMC with flow cytometry. After incubation, PBMC were treated with citrate buffer and washed twice, and a total of 1 ϫ 10 5 PBMC were overlaid directly on the EC monolayer ("contact"), or, alternatively, placed into a Transwell insert (Corning Transwell support system) without direct contact between EC and PBMC ("no-contact"). In the "no-contact" situation, PBMC shared the same environment as EC through 0.4-m pores in the insert, but PBMC were physically separated from the monolayer. The "no-contact" situation was used to evaluate the efficacy of the citrate treatment of PBMC to inactivate nonpenetrated virus. In the "contact" situation, experiments were done in the presence of a 1:100 dilution of an EHV-1/ EHV-4-neutralizing antiserum (VNA) with a titer of 1:2,048 (18) . All cells were incubated for 24 h prior to counting GFP-positive plaques on the EC monolayer using an inverted fluorescence microscope (Zeiss Axiovert 100).
Confocal microscopy. For detection of EHV-1 replication within infected PBMC, cells were infected with mRFP1-labeled EHV-1 at an MOI of 5 for at 37°C for 1 h. After washing, PBMC were incubated at 37°C for 24 h and then fixed with 3.5% paraformaldehyde for 15 min and inspected with a Zeiss LSM 510 confocal microscope using a 63ϫ oil immersion objective.
Flow chamber assay. Ten million PBMC were infected with either parental (EHV-1 or EHV-4), mutant (EHV-1⌬US3), or recombinant (EHV-1_US3_4) virus as described above (39) and incubated for 24 h. GFP-positive cells were then isolated by fluorescence-activated cell sorting (FACS) using a FACSAria (BD Biosciences) from the gated PBMC population. Sorted PBMC were then fluorescently labeled with CellVue Jade Dye (Polysciences Inc.) for 5 min according to the manufacturer's instructions. After staining, PBMC were washed three times and resuspended in medium containing VNA with a titer of 1:2,048 at a dilution of 1:100.
EC were grown to confluence in -Slide 0.4 VI collagen IV-coated cell flow chambers (Ibidi Integrated BioDiagnostics) that were connected to a perfusion system by Luer locks (Ibidi Integrated BioDiagnostics). The flow chamber was mounted within an Ibidi heating system, universal fit (Ibidi Integrated BioDiagnostics), maintaining a temperature of 37°C. This allowed the introduction of 5 ϫ 10 4 PBMC to study leukocyte-endothelial interactions at a flow rate of 0.5 mm/s, which is within the mammalian physiological range of 0.34 to 3.15 mm/s (40) . The velocity was calculated according to the size of the chamber and the velocity in mammalian brain capillaries and was generated by a NE-4000 double-syringe pump (New Era Pump System).
PBMC-EC interactions were visualized with an Olympus IX-81 inverted fully motorized fluorescence microscope (Olympus) with a 10ϫ/0.25 Zeiss Achrostigmat (Carl Zeiss) objective and a mercury arc lamp (HBO). Tiff stacks of 500 images were acquired at 3.42 frames/s with a monochrome CCD camera (Clara; Andor Technology) and MetaView imaging acquisition and analysis software (Molecular Devices). Image processing and automated tracking of rolling PBMC was accomplished in the FIJI package of ImageJ (www.fiji.sc) (41) . The processed images were assembled as a stack of tiff images and analyzed for rolling speed and number of rolling cells per video using the TrackMate plugin. TrackMate first identified fluorescent cells in each image of the stack, given an estimated diameter of the cells (15 pixels with a lateral pixel resolution of 323 nm by 323 nm) and a threshold value for the minimum fluorescence intensity. Next, the plugin linked the fluorescent cells between frames using a frame-to-frame maximum linking distance of 90 pixels. To obtain the actual rolling speed in micrometers per second, the resulting mean velocities in pixels per frame were corrected for the frame rate of 3.42 frames/s and the pixel distance of 0.645 m/pixel [v (m/s) ϭ v (pixels/frame) ϫ 3.42 frames/s ϫ 0.645 m/ pixel]. Passing debris or floating cells that were falsely included in the analysis were manually removed from the tracks using the plugin.
After 24 h of incubation, GFP-positive plaques on the EC monolayer were counted (excluding the inlet/outlet areas) using an inverted fluorescence microscope (IX-81; Olympus).
Statistical analysis. Statistical analyses (described in context) were performed using GraphPad PRISM 5 (Intuitive Software for Science). Normally distributed data sets, determined with the Shapiro-Wilk test, were analyzed with one-way analysis of variance (ANOVA). Data sets that were not normally distributed were analyzed with the Mann-Whitney U test for two-way analysis of variance or the Kruskal-Wallis test for oneway analysis of variance for more independent samples. Normally distributed grouped samples were analyzed with two-way ANOVA. In order to compensate for the large differences in data set sizes of the mean velocities of rolling infected PBMC, 100 randomly equally sized subsets (their size being limited by the smallest data set) were selected from each data set using randomization loop (R software) and were then analyzed with Kruskal-Wallis one-way analysis of variance and corrected with the Holm-Sidak multiple-comparison test (42) . Data sets significantly differing at least 95 times out of the 100 analyzed randomizations were then considered significantly different.
RESULTS

Growth analysis and rates of infection by EHV-1 and EHV-4 in PBMC.
Three independent growth kinetic experiments were performed for EHV-1 and EHV-4. The results showed that viral titers did not increase exponentially over time as normally seen during productive infection in cultured (ED) cells. On the contrary, titers of EHV-4 significantly decreased over time compared to those of EHV-1, which remained stable (Fig. 1a) . The rates of infection of PBMC with EHV-1 or EHV-4 did also not significantly increase over the 48-h infection period, a finding commensurate with the absence of production of infectious virus in PBMC. Comparing PBMC infection rates at 12 h p.i., we could also show that both viruses infect PBMC with similar efficiencies. However, the number of infected cells increased (EHV-1) or decreased (EHV-4) over the course of 48 h when cells were infected at an MOI of 1 (Fig. 1b) . The slight increase of EHV-1 titers could be caused by aggregation of infected PBMC, enabling cell-to-cell transfer of virus, as described earlier (43) . Indeed, when the abilities of EHV-1 and EHV-4 to aggregate were compared, EHV-4 was not able to induce aggregation of PBMC to the same extent as EHV-1 (Table 1 and Fig. 1c to e) .
Finally, newly formed RFP-labeled EHV-1 nucleocapsids could be visualized within the nucleus after 24 h p.i. (Fig. 1f) . The nuclear localization of capsid proteins is indicative of de novo production of nucleocapsids.
Rates of infection of different PBMC subpopulations by EHV-1 and EHV-4. The compositions of the three main PBMC subpopulations (mean Ϯ standard deviation [SD]) were determined by flow cytometry. The percentages were 88.82% Ϯ 0.84% CD3 ϩ T lymphocytes, 2.60% Ϯ 1.47% CD14 ϩ monocytes, and 8.57% Ϯ 1.6% IgM ϩ B lymphocytes, which are still within the ranges of previously obtained values (11, 44) . The rate of infection by parental EHV-1 and EHV-4 was determined for each PBMC subpopulation (mean Ϯ SD). EHV-1 was able to infect both monocytes (41 (Fig. 2) .
gB plays an important role in direct virus transfer from infected PBMC to EC. Experiments were conducted to study virus transfer from PBMC that had been infected with parental or recombinant EHV-1 and EHV-4 in either the "contact" or "nocontact" model. Parental EHV-1 was able to infect EC in the presence of neutralizing antibody only in the "contact" model (Fig. 3,  lane 1) . Interestingly, EHV-4 was unable to spread (under contact conditions) from infected PBMC to EC, as evidenced by the absence of any plaque formation (Fig. 3, lane 5) , although the EC preparations used were permissive for EHV-4 infection using free infectious virus produced on ED cells (data not shown) (39) . When evaluating EHV-1_gB4 and its revertant EHV-1_gB1r, significantly decreased plaque numbers could be seen for EHV1_gB4 compared to parental EHV-1 and the revertant EHV1_gB1r ("contact" model; Fig. 3, lanes 3 and 4) . EHV-4_gB1 could not be evaluated because adequate rates of infection of PBMC could not be obtained in our experimental setup (data not shown). EHV-1_gD4 and EHV-4_gD1 did not show a significant difference compared with their respective parental viruses (Fig. 3,  lanes 2 and 6) . In all cases, no virus transfer from infected PBMC to EC was observed under "no-contact" conditions (data not shown).
Tethering and rolling of infected PBMC and viral transfer to EC under flow conditions. After introducing 5 ϫ 10 4 CellVuelabeled and infected PBMC into the flow system, PBMC were seen rolling over the confluent EC monolayer as illustrated by the bright-field tiff stack video of EHV-1-infected PBMC (see Movie S1 in the supplemental material). When counting the PBMC that interacted with the EC monolayer, significant differences in the number of PBMC that tethered and rolled were seen as a function of infection. (Fig. 4a) .
The fluorescent PBMC were tracked by TrackMate throughout the consecutive images of the tiff stack. Measuring displacement between images and calculating the mean velocities for each track resulted in tracks that were color-labeled according to speed (blue [slow] to red [fast]) (see Movie S2 in the supplemental material). The mean velocity of rolling PBMC was measured for mock-infected PBMC and PBMC infected with parental EHV-1, EHV-4, and mutant (EHV-1⌬US3) and recombinant (EHV-1_US3_4) viruses. The collected data were compared for differences in rolling speed as described in Materials and Methods. We determined no significant differences in rolling speeds (mean velocity Ϯ SD) for (Fig. 4b) .
As already shown in the stationary setup, plaque formation was not seen for the EHV-4-infected PBMC. Only parental EHV-1 (17.33 Ϯ 9.31 plaques), EHV-1_US3_4 (20 Ϯ 5.29 plaques), and, to a significantly lesser extent, EHV-1⌬US3 (2 Ϯ 1 plaques) were able to transfer between infected PBMC and EC ( Fig. 4c and d) . Preliminary findings did not show any differences between EHV1_gB4 and parental EHV-1 (data not shown), and therefore, EHV-1_gB4 was not further analyzed in this setup.
DISCUSSION
Infection of PBMC arguably is the decisive step in the pathogenesis of EHV-1 and related herpesviruses such as PRV, because it enables the virus to evade the immune system while spreading systemically (5, 9, 10, 15, 16, 45, 46) . Interestingly, lower viral titers were seen over time for EHV-4-infected PBMC, while the titers of EHV-1-infected PBMC remained constant. Even though the differences were minor due to relatively low PBMC infection rates, this is an indication that EHV-1 and EHV-4 go through and/or induce distinctly different intracellular processes after PBMC entry. Another characteristic seen only for EHV-1 was a slightly increasing trend in PBMC infection rates over time. This could be explained by the differing abilities of the two viruses to cause aggregation of the infected PBMC, which creates intimate intercellular contact that has been reported to facilitate EHV-1 spread (43) .
When the replication of EHV-1 and EHV-4 was evaluated in PBMC, the lack of increase in titers and infection rates over time indicated that there was no productive infection; however, this does not exclude the possibility that there is some productive virus replication, albeit at low levels. Our results confirm the findings reported previously by Scott et al. and van der Meulen et al. (12, EHV-4. PBMC were infected with EHV-1 or EHV-4 (MOI of 1), washed, and then incubated for 24 h. After incubation, the percentage of infected cells for each subpopulation relative to the total number of cells within the subpopulation was determined by flow cytometry. Significant differences (*) were seen (P Ͻ 0.05) between EHV-1 and EHV-4 for monocytes and B lymphocytes, where EHV-1 achieved higher infection rates (n ϭ 6; one-way ANOVA).
FIG 3
Infection of EC by PBMC-associated EHV-1 and EHV-4. PBMC were infected with recombinant or parental EHV-1 or EHV-4 (MOI of 0.1). An overlay with infected PBMC was performed on EC incubated in medium containing neutralizing antibodies. After 24 h of incubation at 37°C, plaques were counted. Significant differences in plaque numbers (*) were seen between parental EHV-1 and EHV-4 and between parental/revertant EHV-1 and EHV1_gB4 (n ϭ 4; Kruskal-Wallis one-way analysis of variance, P Ͻ 0.05). 47); the latter study referred to the phenomenon as replication "in a highly restricted way." We did, however, observe differences in PBMC (total and subpopulation) infection rates between our and previous findings (11, 48) . The most important factors that could explain the discrepancies are the differences in virus strains used and the methods used for measuring infection. That low-level replication was taking place was also confirmed by the use of a recombinant virus that expresses an mRFP-labeled capsid protein, for which de novo production of a smaller number of nucleocapsids was detected in the nuclei of infected PBMC. This is in accordance with the hypothesis of restricted replication as defined previously by van der Meulen and colleagues (11) . Interestingly, an absence of viral envelope protein expression, both intracellularly and on the cell surface of infected PBMC, has been reported in vivo. It was hypothesized that the production of envelope proteins may be triggered by events such as adhesion of the PBMC to susceptible cells (EC) (49) . It is still unclear why some late gene products are produced and others are not. Similar observations were also made for other alphaherpesviruses, such as HSV and PRV, where only very limited replication was seen in mononuclear cells (50, 51) . However, envelope protein expression was seen during PRV infection of monocytes. It was suggested that an antibody-induced internalization mechanism of envelope proteins presented on the cell surface was adopted by PRV in order evade host immune responses (52) . In addition, transcription of envelope proteins was detected after infection of PBMC with VZV, another alphaherpesvirus with an important cell-associated viremic phase (53) . This is in stark contrast with events during monocyte infection by betaherpesviruses, such as HCMV, where viral gene expression is seen only after the monocytes differentiate into macrophages (54) .
This limited replication of alphaherpesviruses attributes to PBMC an important role in the pathogenesis (9, 11, 15) . Fully productive infection would impede normal PBMC function and possibly induce a cytotoxic-T-lymphocyte (CTL)-based immune response targeting the infected PBMC, which would result in their elimination before virus could systemically spread.
We show here that monocytes were the most highly infected PBMC, which is consistent with the results of van der Meulen et al. (11) . We could also see differences between EHV-1 and EHV-4 in their ability to infect monocytes and B-lymphocyte subpopulations. In both cases, EHV-1 achieved significantly higher infection rates than EHV-4. This reduced capability of EHV-4 to infect monocytes and B lymphocytes could partly explain the weak and short cell-associated viremia seen in vivo for EHV-4 (7). However, further studies are needed to address the downstream mechanisms following PBMC infection, which allows, in the case of EHV-1, but not EHV-4, transfer to EC. Monocytes are the main leukocyte target of several herpesviruses, which is likely facilitated by a distinct characteristic of these cells, namely, the restriction of a fully productive infection (11, 15, 46, 55, 56) . This lack of complete replication and production of virus in monocytes during the viremic phase allows the viruses to spread throughout the host while simultaneously evading the immune system.
It is known that EHV-1-infected PBMC are responsible for transporting the virus to the endothelia of the gravid uterus and/or the CNS, where it can cause severe symptoms, even resulting in death (33, 57) . We could confirm that cell-associated EHV-1 was able to infect EC through direct cell-to-cell contact, as previously reported by Goehring et al. (18) . Strikingly, we saw that cell-associated EHV-4 was not able to infect EC in the presence of neutralizing antibody. This is of importance given the absence of vasculitis during EHV-4 infection. It also supports our hypothesis that EHV-1 and EHV-4 go through distinctly different intracellular processes and differentially manipulate PBMC after entry. The exchange of gB in EHV-1 with its EHV-4 counterpart had a marked effect on viral transfer between infected PBMC and EC, despite the exchange having no significant effect on viral growth in vitro (20) . EHV1_gB4 showed a significantly attenuated ability to transfer to the EC monolayer, indicating an important role of EHV-1 gB in this process of virus transfer and PBMC aggregation in vitro. These results add a new facet to the previously reported role of EHV-1 gB in facilitating direct cell-to-cell spread (19) .
Striking differences were seen between EHV-4-and EHV-1-infected PBMC with regard to the number of PBMC able to tether and roll on EC. While EHV-1-infected PBMC were able to tether, roll, and transfer the virus to EC, many EHV-4-infected PBMC seemed unable to roll over the EC monolayer, which marks another difference in the course of disease that would prevent EHV-4 from causing vasculitis. This indicates that, apart from differences in adhesion molecules on the EC surface affecting PBMC-EC interaction (8) , changes in the infected PBMC also affect this process. Such changes could be influencing the expression of adhesion molecules on the surface of PBMC either through a direct effect of the virus (58) or because of apoptosis that can induce downregulation of adhesion molecules as seen in neutrophils (59) . We propose that downregulation of adhesion molecules on the cell surface could explain this reduced ability to tether and roll. This was supported by our recent findings that EHV-4, but not EHV-1, was capable of downregulating VLA-4 adhesion molecules expressed on the surface of infected cells (25) . Under flow conditions, no attenuating effect on viral transfer of EHV-1 was seen when gB1 was exchanged with gB4. Although this might indicate that the differences between gB1 and gB4 are not important under flow conditions, we believe that more complex mechanisms are taking place during virus transfer. Support for this hypothesis comes from data showing that exchanging gB1 with gB4 results in differences in viral transfer in a static setting, even though this caused no difference in in vitro growth (20) . This indicates that the process of viral transfer is quite sensitive to changes in gB, possibly indicating that gB is very important for the successful execution of this process.
On the other hand, we showed also that deleting US3 decreased the ability of infected PBMC to tether and roll. This could be caused by a number of factors, since the described functions of pUS3 are very diverse. pUS3-mediated actin rearrangement might influence adhesion molecule expression on infected PBMC (27, 29) , thereby negatively influencing tethering and rolling. Furthermore, without the antiapoptotic effects of pUS3, infected cells might also undergo apoptosis, which negatively influences cell surface adhesion molecule expression and may eliminate PBMC before EHV-1 is able to transfer to the EC. When evaluating the dynamic characteristics of infected PBMC that were still able to tether and roll, no changes regarding their rolling speed were seen. This suggests that rolling speed does not factor into the process of viral transfer. This is in accordance with previous reports which showed that the main determinants for the leukocyte rolling velocity were the flow rate and the characteristics of the substrate on which the leukocytes roll, rather than differences between leukocytes themselves. Furthermore, it was proposed that heterogeneity in P-selectin expression on the endothelium likely plays an important role in the variation of rolling velocities (60) . It is also remarkable that EHV-1-infected PBMC show no significant differences from mock-infected PBMC regarding rolling speed and number of rolling cells. Keeping immune cell function normal after infection is essential to facilitate the spread of EHV-1 throughout the body by cell-associated viremia.
The results obtained from the growth kinetics, Transwell, and flow chamber assays all indicate that EHV-1 infection and EHV-4 infection of PBMC have very different impacts on infected PBMC. It is therefore of great interest to screen for differences in expression of cellular proteins, for example, by means of microarrays or RNA sequencing and quantitative mass spectrometry, in order to determine the underlying mechanisms for these specific phenotypes. Furthermore, other viral glycoproteins, such as gC, will be further investigated for their role in PBMC infection. gC has been shown to be involved in EHV-1 spread and has characteristics different from those of EHV-4 gC (37, 61) . Exchanging these genes and evaluating the recombinant viruses in PBMC could then give more insight on virus infection and transfer.
In summary, we have established an experimental setup that for the first time allows the evaluation of the dynamic alphaherpesvirus-infected PBMC-EC interactions. Our data support a model where circulating infected PBMC remain normal in function with regard to their interactions with EC, thanks in part to pUS3. Once they are firmly attached to the EC lining of the blood vessels, virus transfer can occur between the infected PBMC and EC, which is facilitated by gB, under in vitro conditions. This is then followed by productive infection in the EC lining of the blood vessel, inducing a strong immune response (Fig. 5) .
